SOVREMENNAYA PEDIATRIYA.2016.7(79):12-19; doi 10.15574/SP.2016.79.12 

Omega-3 polyunsaturated fatty acids — a key vector in prevention of the children's health 

Berezhnoi V. V., Korneva V. V.

Shupik National Medical Academy of Postgraduate Education, Kiev, Ukraine

In the article the scientific review of domestic and foreign medical literature devoted to the analysis of the role of omega-3 polyunsaturated fatty acids (PUFAs) — the most important factor of the cell membrane of essential nutrition is presented. The medical effects of omega-3 PUFAs are analyzed. The omega-3 has particular importance in children, first of all for the correct formation and normal functioning of the brain and nervous system as in utero so from the first days of life; during the periods of intense growth and stress coming from learning. A wide range of curative effects, almost universality of omega-3 PUFAs preparations explain its efficacy in various diseases, as well as during the «background» conditions. Therefore, the use of preparation with omega-3 fatty acids in the treatment of vegetative syndromes, autonomic dysfunction in children is an important corrector of cerebro-intestinal and cerebro-cardiac disorders and other interactions. Prospective in this direction is "Reytoil" preparation, which can be used from the age of three years (2–3 base courses during the year), especially at periods of children's adaptative loads.

Key words: children, the omega-3 polyunsaturated fatty acids, vegetative syndromes, Reytoil.

REFERENCES

1. Berezhnyi VV, Marushko TV, Marushko YeIu. 2014. Vplyv kompleksnoho likuvannia z vkliuchenniam preparatu omeha-3 polinenasychenykh zhyrnykh kyslot na stan sudyn khvorykh na yuvenilnyi revmatoidnyi artryt. Aktualni pytannia pediatrii, akusherstva ta hinekolohii. 2(14): 7—9.

2. Biohimiya. Pod red. ES Severina. Moskva, Geotar-Med. 2004: 417—426.

3. Golusenko IYu. 2004. Fonovoe lechenie atopicheskogo dermatita nezamenimyimi zhirnyimi kislotami Omega 3 i Omega 6. Vestnik dermatol i venerol. 3: 58—59.

4. Hopchuk OM. Zastosuvannia polinenasychenykh zhyrnykh kyslot Omeha-3 u kompleksnii terapii hiperandrohennykh staniv. http://medstrana.com/articles/6504/.

5. Gorelova Zh.Yu. 1999. Rol polinenasyischennyih zhirnyih kislot v lechebnom pitanii detey s allergicheskimi zabolevaniyami. Voprosyi pitaniya. 1: 31—35.

6. Gromova OA, Torshin IYu, Egorova EYu. 2012. Omega-3 PNZhK i kognitivnoe razvitie detey. Prakticheskaya meditsina. 2: 12—17.

7. Kon IYa, Shilina NM, Volfson SB. 2006. Omega-3 polinenasyischennyie zhirnyie kislotyi v profilaktike i lechenii bolezney detey i vzroslyih. Kollokvium. Gastroenterologiya. 4: 3—54. http://ru.yhs4.search.yahoo.com/yhs/search?hspart.

8. Korneva VV. 2015. Mediko-sotsialnyie posledstviya defitsita zheleza u detey. Sovremennaya pediatriya. 1: 101—105.

9. Kuzenkova L. M. Namyizova-Baranova L. S., Balkanskaya S. V. 2009. Polivitaminyi i polinenasyischennyie zhirnyie kislotyi v terapii giperaktivnosti, rasstroystv s defitsitom vnimaniya u detey. Pediatricheskaya farmakologiya. 3; 3: 74—80.

10. Lytynska TO. Zastosuvannia omeha-3 polinenasychenykh zhyrnykh kyslot v klinichnii dermatolohii. http://worldmedicine.md/ru/main/textpage3/190.

11. Maidannyk VH. 2016. Kryterii diahnostyky ta pidkhody do likuvan porushen tse rebro-intestinalnoi vzaiemodii. Zdorovia Ukrainy. Pediatriia: 12—15.

12. Martyinov AI, Cheltsov VV. 2007. Omega-3 polinenasyischennyie zhirnyie kislotyi v kardiologicheskoy praktike. Metodicheskie rekomendatsii. Moskva: 22.

13. Marushko YuV, Ostapenko YuIu. 2013. Dosvid zastosuvannia kapsul Smart Omeha dlia ditei z metoiu polipshennia kohnityvnykh funktsii. Dytiachyi likar. 3: 51—54.

14. Oganov RG, Perova NV. 2005. Omega-3 polinenasyischennyie zhirnyie kislotyi v profilaktike serdechno-sosudistyih zabolevaniy, svyazannyih s aterotrombozom. RMZh. 13; 19: 1309—1313.

15. Pediatriia: natsionalnyi pidruchnyk. U 2 t. Za red prof VV Berezhnoho. Kyiv. 2013. 1: 828—856.

16. Perova NV. 2005. Omega-3 polinenasyischennyie zhirnyie kislotyi v kardiologii. Kardiovaskulyarnaya terapiya i profilaktika. 4(4): 101—107.

17. Kvashnina LV, Ignatova TB, Rodionov VP, Makovkina YuA. 2013. Approaches to the treatment of children with vegetative dysfunction occurring with lipid metabolism disorders and endothelial disfunction. Sovremennaya pediatriya. 8: 102—109.

18. Popov SV, Melekhovets OK, Demikhova VN. Zastosuvannia reitoilu v profilaktytsi aterosklerozu u khvorykh na tsukrovyi diabet. http://worldmedicine.md/ru/main/textpage3/189.

19. Prohorovich EA. 2006. Polinenasyischennyie zhirnyie kislotyi klassa omega-3 v profilaktike i lechenii arterialnoy gipertonii i ee osloneniy. Praktikuyuschiy vrach. 1: 2—5.

20. Serhiienko VO, Serhiienko OO. 2016, Berezen. Dovholantsiuhovi Omeha-3-polinenasycheni zhyrni kysloty: sertsevo-sudynni zakhvoriuvannia i tsukrovyi diabet. Zdorovia Ukrainy: 30—31.

21. Sirenko YuN, Kushnir SN. 2012. Vliyanie omega-3 polinenasyischennyih zhirnyih kislot na funktsionalnyie svoystva sosudov u bolnyih arterialnoy gipertenziey. UkraYinskiy med chasop. 4(90): 117—120.

22. Tkach SM. 2016. Samoe ozhidaemoe sobyitie goda v gastroenterologii: Rimskie kriterii IV funktsionalnyie gastrointestinalnyie rasstroystva. 29.06.2016. https://medprosvita.com.ua/vnimaniyu-gastroenterologov/.

23. Tsentr ekspertiz. Test. Spravochnik potrebitelya. https://test.org.ua/tests/health-cosmetics/489.

24. Yakovleva OA, Marchenko KG, Kosovan AI. 2008. Omega-3 zhirnyie kislotyi: ot fiziologicheskogo znacheniya k dokazatelnoy meditsine. Ratsionalnaya farmakoterapiya. 2: 42—46.

25. Yaremenko OB. 2001. Omega-3 polinenasyischennyie zhirnyie kislotyi v revmatologii: teoreticheskie osnovyi. Ukrainskyi revmatolohichnyi zhurnal. 2(4): 23—30.

26. Bjorneboe A, Soyland Е, Bjorneboe GE. 1987. Effect of dietary supplementation licosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol. 117: 463—9.

27. Carl J, Lavie MD, Richard V. 2009. Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. J Am Coll Cardiol. 54: 585—594.

28. Drossman DA. 2016. Functional Gastrointestinal Disorders: History Pathophysiology, Clinical Features, and Rome IV. Gastroenterology. 150(6): 1262—1279. https://doi.org/10.1053/j.gastro.2016.02.032

29. Dyerberg J. 1989. Coronary heart disease in Greenland Inuit: A paradox. Implication for Western diet patterns. Artie Med Res. 48: 47—54.

30. Dyerberg J, Bang HO, Hjorne N. 1975. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin-Nutr. 28: 958—66.

31. Mozaffarian D, Psaty ВМ, Rimm ЕВ et al. 2004. Fish intake and risk of incident atrial fibrillation. Circulation. 110: 368—73.

32. Gupta AK, Ellis CN, Tellnes DC. 1989. Double-blind, placebo-controlled study to evaluate the efficacy of fish oil and low-dose UVB in the treatment of psoriasis. Br J Dermatol. 120: 801—7.

33. Harris WS, Poston WC, Haddock СК. 2007. Tissue w-3 and w-6 fatty acids and risk for coronary heart disease events. Atherosclerosis. 193: 1—10.

34. Koletzko В, Agostoni С, Carlsson S et al. 2001. Long chain polyunsaturated fatty acid (LC-PUFA) and perinatal development. Acta Paediatr Scand. 90: 460—465.

35. Maсy О. 2007. Omega-3 Supplements May Slow A Biological Effect of Aging «Dietary (w-3) fatty acids and brain development. J Nutr. 137(4): 855—859.

36. Richardson AJ, Montgomery Р. Аttention deficit disorder, hyperactivity. http://pku.org.ua/organization/consultation/Giperaktivnost/http://www.sweli.ru/deti/starshe-7/razvitie-i-vospitanie-shkolnika/sindrom-defitsita-vnimaniya-s-giperaktivnostyu-u-detey-sdvg-u-detey.html.

37. William H. 2008. Omega-3 fatty acids: the «Japanese» factor? J Am Coll Cardiol. 52: 425—7.